2014 CVM News: Optogentic toolkit will shed light on cardiac, lung, blood, and immune disease

Office of Marketing and Communications. Media Relations

eCommons will become read-only at noon on May 26 for an infrastructure update. Submissions will not be accepted at this time. We anticipate that this update will be completed by June 2 at 5 p.m.

Please contact us at ecommons-admin@cornell.edu if you have questions or concerns.

Show simple item record

dc.contributor.author	Office of Marketing and Communications. Media Relations
dc.date.accessioned	2017-07-10T18:36:07Z
dc.date.available	2017-07-10T18:36:07Z
dc.date.issued	2014-09-09
dc.identifier.uri	https://hdl.handle.net/1813/51864
dc.description.abstract	This news item is about: New technologies involving optogenetic proteins, which use light to control and observe cells with unprecedented precision, have begun to illuminate processes underlying cellular behavior and the effects of cell and gene–based therapies. Cornell researchers are developing advanced forms of these proteins to form a toolkit to make them more widely available to scientists. With a five year $3.1 million grant from the National Heart, Lung, and Blood Institute, the team will develop the Cornell Heart, Lung, and Blood Resource for Optogenetic Mice (CHROMus), which will incorporate optogenetic proteins in mice and human stem cells. Scientists use such tools to control and observe how different types of cells function and interact.
dc.language.iso	en_US
dc.publisher	Cornell University, College of Veterinary Medicine
dc.subject	Cornell University. College of Veterinary Medicine -- Periodicals.
dc.subject	Kotlikoff, Michael I.
dc.title	2014 CVM News: Optogentic toolkit will shed light on cardiac, lung, blood, and immune disease
dc.type	article